Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shandong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

     

    Dexlansoprazole with CAS 138530-94-6 is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals.

    Dexlansoprazole (CAS 138530-94-6), Chemically, is an enantiomer of lansoprazole. The compound was launched in the US for use in the treatment and maintenance of patients with erosive oesophagitis and non-erosive gastro-oesophageal reflux disease (GERD or GORD).

    The product above are not for sales where the patents are applicable and still valid.

     

Send your message to this supplier
  • From:
  • To:
    Viwit Pharmaceutical Co., LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service